JFJulia Fleming

Julia Fleming

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Julia Fleming has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Bo Li

    Center for Computational and Genomic Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    1 shared publication
  • Hailong Hu

    School of Life Science and Technology, State Key Laboratory of Urban Water Resource and Environment, Harbin Institute of Technology, Harbin, China

    1 shared publication
  • Jing Hu

    Center for Computational and Genomic Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    1 shared publication
  • Mingyao Pan

    Department of Bioengineering, School of Engineering, University of Pennsylvania, Philadelphia, PA, USA

    1 shared publication
  • Xiaowei Zhan

    Quantitative Biomedical Research Center, Department of Population and Data Sciences, University of Texas Southwestern Medical Center

    1 shared publication
  • Yizhou Tracy Wang

    Center for Computational and Genomic Medicine, The Children’s Hospital of Philadelphia, Philadelphia, PA, USA

    1 shared publication

Latest Publications

  • Open Access

    Quantitative and large-scale investigation of human TCR-HLA cross-reactivity

    by Mingyao Pan, Yuhao Tan, Yizhou Tracy Wang, Jing Hu, Julia Fleming, Hailong Hu, Ziqi Yang, Xiaowei Zhan, Bo Li

    The interaction between human leukocyte antigens (HLAs) and T cell receptor (TCR) is essential for adaptive immune recognition. While it is known that one TCR can map to multiple HLA alleles, the extent of this cross-reactivity remains poorly understood. Here, we introduce THNet, a TCR-based HLA similarity network, and present a comprehensive analysis of HLA-TCR cross-reactivity, which is built upon more than 9 million significantly associated HLA-TCR pairs. We created similarity networks for both class I and class II HLA alleles, illustrating how peptide cross-presentation contributes to HLA-TCR cross-reactivity. Our analysis revealed disease susceptibilities missed by single-HLA enrichment analyses, especially in the Black population. Last, we demonstrated that THNet can prioritize optimal HLA mismatch candidates across different transplantation contexts, supporting its potential utility in donor selection strategies. In summary, our investigation of the HLA-TCR cross-reactive network provides useful insights into autoimmune risk prediction and improved transplantation outcomes.